Skip to content
PICO Portalanswers from OpenAlex

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PaperCitations, authors & open-access status

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer have?

PICO Portalcitation count

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has 154 citations in the OpenAlex counts PICO Portal stores.

When was PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer published?

PICO Portalyear

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has 2018 year in the PICO Portal index.

What is the open-access status of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?

PICO Portaloa status

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has gold oa status in the PICO Portal index.

What is the DOI of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?

PICO Portaldoi

The DOI for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.

What is the PMID of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?

PICO Portalpmid

The PMID for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.

What is the OpenAlex record for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?

PICO Portalopenalex

The OpenAlex for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial